Electrophysiological and Imaging Calcium Biomarkers of Aging in Male and Female 5×FAD Mice.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 10 11 2020
medline: 30 9 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

In animal models and tissue preparations, calcium dyshomeostasis is a biomarker of aging and Alzheimer's disease that is associated with synaptic dysfunction, neuritic pruning, and dysregulated cellular processes. It is unclear, however, whether the onset of calcium dysregulation precedes, is concurrent with, or is the product of pathological cellular events (e.g., oxidation, amyloid-β production, and neuroinflammation). Further, neuronal calcium dysregulation is not always present in animal models of amyloidogenesis, questioning its reliability as a disease biomarker. Here, we directly tested for the presence of calcium dysregulation in dorsal hippocampal neurons in male and female 5×FAD mice on a C57BL/6 genetic background using sharp electrodes coupled with Oregon-green Bapta-1 imaging. We focused on three ages that coincide with the course of amyloid deposition: 1.5, 4, and 10 months old. Outcome variables included measures of the afterhyperpolarization, short-term synaptic plasticity, and calcium kinetics during synaptic activation. Quantitative analyses of spatial learning and memory were also conducted using the Morris water maze. Main effects of sex, age, and genotype were identified on measures of electrophysiology and calcium imaging. Measures of resting Oregon-green Bapta-1 fluorescence showed significant reductions in the 5×FAD group compared to controls. Deficits in spatial memory, along with increases in Aβ load, were detectable at older ages, allowing us to test for temporal associations with the onset of calcium dysregulation. Our results provide evidence that reduced, rather than elevated, neuronal calcium is identified in this 5×FAD model and suggests that this surprising result may be a novel biomarker of AD.

Sections du résumé

BACKGROUND
In animal models and tissue preparations, calcium dyshomeostasis is a biomarker of aging and Alzheimer's disease that is associated with synaptic dysfunction, neuritic pruning, and dysregulated cellular processes. It is unclear, however, whether the onset of calcium dysregulation precedes, is concurrent with, or is the product of pathological cellular events (e.g., oxidation, amyloid-β production, and neuroinflammation). Further, neuronal calcium dysregulation is not always present in animal models of amyloidogenesis, questioning its reliability as a disease biomarker.
OBJECTIVE
Here, we directly tested for the presence of calcium dysregulation in dorsal hippocampal neurons in male and female 5×FAD mice on a C57BL/6 genetic background using sharp electrodes coupled with Oregon-green Bapta-1 imaging. We focused on three ages that coincide with the course of amyloid deposition: 1.5, 4, and 10 months old.
METHODS
Outcome variables included measures of the afterhyperpolarization, short-term synaptic plasticity, and calcium kinetics during synaptic activation. Quantitative analyses of spatial learning and memory were also conducted using the Morris water maze. Main effects of sex, age, and genotype were identified on measures of electrophysiology and calcium imaging.
RESULTS
Measures of resting Oregon-green Bapta-1 fluorescence showed significant reductions in the 5×FAD group compared to controls. Deficits in spatial memory, along with increases in Aβ load, were detectable at older ages, allowing us to test for temporal associations with the onset of calcium dysregulation.
CONCLUSION
Our results provide evidence that reduced, rather than elevated, neuronal calcium is identified in this 5×FAD model and suggests that this surprising result may be a novel biomarker of AD.

Identifiants

pubmed: 33164928
pii: JAD200109
doi: 10.3233/JAD-200109
pmc: PMC7836067
doi:

Substances chimiques

Amyloid beta-Protein Precursor 0
PSEN1 protein, human 0
Presenilin-1 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1419-1438

Subventions

Organisme : NIA NIH HHS
ID : R01 AG052934
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG058171
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG057461
Pays : United States

Références

Biomed Res Int. 2016;2016:6701324
pubmed: 27340665
Ann N Y Acad Sci. 1993 Sep 24;695:59-64
pubmed: 8239314
Neurobiol Aging. 2014 Jan;35(1):88-95
pubmed: 23932880
Nat Rev Neurosci. 2002 Nov;3(11):862-72
pubmed: 12415294
J Neurophysiol. 2009 Oct;102(4):2194-207
pubmed: 19675291
Pflugers Arch. 1994 Feb;426(3-4):247-53
pubmed: 8183635
Neurobiol Aging. 2014 Dec;35(12):2713-2725
pubmed: 25044076
J Exp Med. 2018 Jun 4;215(6):1649-1663
pubmed: 29724785
Bioessays. 2015 Jun;37(6):624-32
pubmed: 25773221
Neurobiol Aging. 2012 May;33(5):1001.e1-6
pubmed: 21531043
J Neurophysiol. 1998 Jul;80(1):350-64
pubmed: 9658056
Alzheimers Dement. 2016 Apr;12(4):459-509
pubmed: 27570871
eNeuro. 2016 Nov 28;3(6):
pubmed: 27957527
J Anat. 2011 Jul;219(1):78-89
pubmed: 21323664
J Alzheimers Dis. 2015;45(4):1223-36
pubmed: 25697701
Neurochem Int. 2008 Mar-Apr;52(4-5):621-33
pubmed: 18035450
Neurol Clin. 1993 Nov;11(4):787-804
pubmed: 8272032
Invest Ophthalmol Vis Sci. 2009 May;50(5):2351-8
pubmed: 19074809
Neurobiol Dis. 1998 Jul;5(1):37-45
pubmed: 9702786
Neurobiol Aging. 1987 Jul-Aug;8(4):345-6
pubmed: 3627349
Science. 2019 Aug 9;365(6453):559-565
pubmed: 31395777
Science. 2002 Oct 25;298(5594):789-91
pubmed: 12399581
Neurobiol Aging. 2003 Dec;24(8):1047-62
pubmed: 14643376
J Alzheimers Dis. 2015;45(2):561-80
pubmed: 25589721
Learn Mem. 2006 Sep-Oct;13(5):584-9
pubmed: 17015855
Brain Res. 1978 Jul 7;150(1):85-101
pubmed: 208716
Nat Commun. 2016 Nov 11;7:13441
pubmed: 27834383
Methods Mol Biol. 2018;1750:341-351
pubmed: 29512084
Rev Neurosci. 2010;21(3):153-71
pubmed: 20879690
J Neurol Neurosurg Psychiatry. 1995 May;58(5):570-6
pubmed: 7745404
J Cell Mol Med. 2010 Jan;14(1-2):30-41
pubmed: 19929945
C R Seances Soc Biol Fil. 1994;188(5-6):469-86
pubmed: 7780790
Neuron. 2014 Apr 2;82(1):79-93
pubmed: 24698269
N Engl J Med. 1985 Apr 18;312(16):1063-5
pubmed: 3982463
J Neurophysiol. 1992 May;67(5):1346-58
pubmed: 1597717
Neurosci Res. 2019 Apr;141:36-42
pubmed: 30120962
Biochem Biophys Res Commun. 2017 Feb 19;483(4):998-1004
pubmed: 27641664
Science. 1984 Nov 30;226(4678):1089-92
pubmed: 6494926
J Neurosci Methods. 1984 May;11(1):47-60
pubmed: 6471907
Hippocampus. 1997;7(6):602-12
pubmed: 9443057
Expert Opin Med Diagn. 2013 Jul;7(4):393-403
pubmed: 23786440
Brain Res Brain Res Rev. 1989 Jul-Sep;14(3):227-43
pubmed: 2553182
Hippocampus. 1992 Oct;2(4):457-68
pubmed: 1284976
Behav Brain Res. 2008 Sep 1;192(1):106-13
pubmed: 18359102
Science. 2008 Sep 19;321(5896):1686-9
pubmed: 18802001
Dement Geriatr Cogn Disord. 2008;25(4):293-300
pubmed: 18311076
J Neurophysiol. 1986 Sep;56(3):797-811
pubmed: 3783221
Neurobiol Learn Mem. 2007 May;87(4):522-35
pubmed: 17276704
Arch Neurol. 1990 Aug;47(8):847-50
pubmed: 2375689
Neuroscience. 2020 Jan 1;424:102-120
pubmed: 31705965
J Neurochem. 2008 Apr;105(1):262-71
pubmed: 18021291
Scanning Microsc. 1988 Jun;2(2):1027-34
pubmed: 3399843
Hum Mol Genet. 2010 Apr 15;19(R1):R12-20
pubmed: 20413653
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1620-5
pubmed: 19164584
J Neurophysiol. 1992 Dec;68(6):2100-9
pubmed: 1491260
Epilepsy Behav. 2009 Jan;14(1):118-20
pubmed: 18782632
Science. 1996 May 17;272(5264):1017-20
pubmed: 8638124
J Neurosci. 2014 May 14;34(20):6910-23
pubmed: 24828645
J Neurosci. 2006 May 10;26(19):5180-9
pubmed: 16687509
J Geriatr Psychiatry Neurol. 1994 Oct-Dec;7(4):230-3
pubmed: 7826492
J Gerontol. 1977 Sep;32(5):523-33
pubmed: 196001
Epilepsy Res. 2001 Dec;47(3):189-203
pubmed: 11738927
Science. 1989 Sep 29;245(4925):1505-9
pubmed: 2781293
J Am Geriatr Soc. 2018 Jul;66(6):1123-1129
pubmed: 29566430
J Neurophysiol. 1996 Jul;76(1):158-74
pubmed: 8836216
FASEB J. 2017 Sep;31(9):4179-4186
pubmed: 28592637
Hippocampus. 1997;7(5):549-58
pubmed: 9347351
Brain Res Mol Brain Res. 2005 Apr 4;134(2):226-38
pubmed: 15836920
Neuron. 2019 Feb 6;101(3):399-411.e5
pubmed: 30595332
Neurobiol Aging. 1987 Jul-Aug;8(4):346-7
pubmed: 3627350
Nat Commun. 2014 Nov 19;5:5422
pubmed: 25406732
Channels (Austin). 2011 Jan-Feb;5(1):9-13
pubmed: 21139422
Neuroscience. 2015 Dec 3;310:549-60
pubmed: 26341908
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2628-32
pubmed: 8464868
PLoS One. 2008 Sep 04;3(9):e3135
pubmed: 18769546
Cell Calcium. 2010 Feb;47(2):183-9
pubmed: 20080301
PLoS One. 2010 Apr 29;5(4):e10405
pubmed: 20454453
Expert Opin Pharmacother. 2018 Aug;19(11):1201-1209
pubmed: 30009650
Cell Calcium. 1999 Jun;25(6):439-52
pubmed: 10579055
Brain Res. 1992 Jul 31;587(1):158-63
pubmed: 1525645
Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):821-8
pubmed: 12740129
J Neurosci. 2005 Aug 3;25(31):7278-87
pubmed: 16079410
J Neurosci. 2010 Jun 23;30(25):8566-80
pubmed: 20573903
Neuromolecular Med. 2010 Mar;12(1):13-26
pubmed: 19757208
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1279-E1288
pubmed: 29358403
Ann N Y Acad Sci. 1994 Dec 15;747:1-11
pubmed: 7847664
J Neurosci. 2006 Oct 4;26(40):10129-40
pubmed: 17021169
Sci China Life Sci. 2011 Aug;54(8):752-62
pubmed: 21786198
Cell Calcium. 2004 Jul;36(1):61-75
pubmed: 15126057
J Neurosci. 2015 Apr 29;35(17):6893-902
pubmed: 25926464
Aging Cell. 2007 Jun;6(3):307-17
pubmed: 17465978
Science. 2009 Feb 27;323(5918):1211-5
pubmed: 19251629
Mol Neurodegener. 2019 Jan 22;14(1):7
pubmed: 30670054
Cell Metab. 2018 Jun 05;27(6):1176-1199
pubmed: 29874566
Life Sci. 1996;59(5-6):413-20
pubmed: 8761329
Front Neurol. 2019 Dec 04;10:1266
pubmed: 31866927
J Neurosci. 2010 Sep 8;30(36):12128-37
pubmed: 20826675
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8740-5
pubmed: 22592800
Epilepsia. 2006 May;47(5):867-72
pubmed: 16686651
Ann N Y Acad Sci. 1989;568:1-4
pubmed: 2629579
Arch Neurol. 2009 Aug;66(8):992-7
pubmed: 19667221
Mol Pharmacol. 2019 Apr;95(4):337-348
pubmed: 30696719
Neurobiol Aging. 2009 Dec;30(12):2053-64
pubmed: 18367293
Exp Gerontol. 1994 May-Aug;29(3-4):431-6
pubmed: 7925761
J Neurosci. 2004 Jan 14;24(2):508-13
pubmed: 14724250
Behav Neurosci. 1985 Dec;99(6):1040-8
pubmed: 3843538
Epilepsia. 1993 May-Jun;34(3):453-68
pubmed: 8504780
Curr Biol. 2016 Apr 4;26(7):956-64
pubmed: 27020746
Epilepsy Res. 2011 Mar;94(1-2):75-85
pubmed: 21300523
Alzheimer Dis Assoc Disord. 1990 Winter;4(4):217-25
pubmed: 2264979
Glia. 2012 Aug;60(8):1227-33
pubmed: 22389222
Neural Plast. 2000;7(3):167-78
pubmed: 11147459
Cell. 2019 Oct 3;179(2):312-339
pubmed: 31564456
J Alzheimers Dis. 2011;26(2):231-7
pubmed: 21593561
J Neurosci. 2006 Mar 29;26(13):3482-90
pubmed: 16571755
J Neurosci Methods. 1995 Jun;59(1):77-83
pubmed: 7475254
Biochim Biophys Acta. 2012 Apr;1822(4):546-9
pubmed: 22265986
Mol Neurodegener. 2011 Aug 26;6(1):63
pubmed: 21871088
Neurobiol Aging. 2011 Aug;32(8):1452-65
pubmed: 19833411
Epilepsia. 2002 Nov;43(11):1296-305
pubmed: 12423378
Channels (Austin). 2014;8(3):230-42
pubmed: 24476841
Neurology. 1986 Sep;36(9):1226-30
pubmed: 3092131
Cell Calcium. 2003 Oct-Nov;34(4-5):385-97
pubmed: 12909083
J Neurobiol. 1992 Nov;23(9):1247-60
pubmed: 1469387
Learn Mem. 2008 Jan 03;15(1):1-5
pubmed: 18174367
Adv Neurol. 1986;44:991-1010
pubmed: 3706029
J Neurophysiol. 2003 Jul;90(1):32-8
pubmed: 12634277
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2733-7
pubmed: 3458232
Adv Neurol. 1986;44:949-66
pubmed: 3706028
Lancet Neurol. 2019 Apr;18(4):406-414
pubmed: 30795987
Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8527-31
pubmed: 1528857
Subcell Biochem. 2012;65:329-52
pubmed: 23225010
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3178-84
pubmed: 18362105
Channels (Austin). 2010 Nov-Dec;4(6):475-82
pubmed: 21139420
Trends Biochem Sci. 1993 Dec;18(12):480-3
pubmed: 8108862

Auteurs

Adam O Ghoweri (AO)

UKMC MS313, Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.

Lara Ouillette (L)

5037 BSRB, Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.

Hilaree N Frazier (HN)

UKMC MS313, Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.

Katie L Anderson (KL)

UKMC MS313, Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.

Ruei-Lung Lin (RL)

UKMC MS313, Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.

John C Gant (JC)

UKMC MS313, Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.

Rachel Parent (R)

5037 BSRB, Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.

Shannon Moore (S)

5037 BSRB, Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
5037 BSRB, Molecular and Integrative Physiology, Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI, USA.

Geoffrey G Murphy (GG)

5037 BSRB, Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
5037 BSRB, Molecular and Integrative Physiology, Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI, USA.

Olivier Thibault (O)

UKMC MS313, Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH